Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 4
2018 1
2019 4
2020 3
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for 18F-AV-1451 tau pet imaging correlates strongly
Your search for 18F-AV-1451 taru PET imaging correlates strongly retrieved no results
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
Smith R, Puschmann A, Schöll M, Ohlsson T, van Swieten J, Honer M, Englund E, Hansson O. Smith R, et al. Brain. 2016 Sep;139(Pt 9):2372-9. doi: 10.1093/brain/aww163. Epub 2016 Jun 29. Brain. 2016. PMID: 27357347 Free PMC article.
Tau positron emission tomography ligands provide the novel possibility to image tau pathology in vivo However, little is known about how in vivo brain uptake of tau positron emission tomography ligands relates to t …
Tau positron emission tomography ligands provide the novel possibility to image tau pathology in vivo How …
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.
Xia C, Makaretz SJ, Caso C, McGinnis S, Gomperts SN, Sepulcre J, Gomez-Isla T, Hyman BT, Schultz A, Vasdev N, Johnson KA, Dickerson BC. Xia C, et al. JAMA Neurol. 2017 Apr 1;74(4):427-436. doi: 10.1001/jamaneurol.2016.5755. JAMA Neurol. 2017. PMID: 28241163 Free PMC article.
OBJECTIVE: To examine whether topographical distribution and severity of hyperphosphorylated tau pathologic findings measured by fluorine 18-labeled AV-1451 ([18F]AV-1451) positron emission tomographic (PET) imaging are link …
OBJECTIVE: To examine whether topographical distribution and severity of hyperphosphorylated tau pathologic findings measured by fluo …
Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease.
Shcherbinin S, Schwarz AJ, Joshi A, Navitsky M, Flitter M, Shankle WR, Devous MD Sr, Mintun MA. Shcherbinin S, et al. J Nucl Med. 2016 Oct;57(10):1535-1542. doi: 10.2967/jnumed.115.170027. Epub 2016 May 5. J Nucl Med. 2016. PMID: 27151986 Free article.
We report kinetic modeling results of dynamic acquisition data from 0 to 100 min after injection with the tau PET tracer (18)F-AV-1451 in 19 subjects. METHODS: Subjects were clinically diagnosed as 4 young cognitively normal, 5 old cognitively normal, 5 mild cogniti …
We report kinetic modeling results of dynamic acquisition data from 0 to 100 min after injection with the tau PET tracer (18)F …
Longitudinal flortaucipir ([(18)F]AV-1451) PET imaging in primary progressive apraxia of speech.
Utianski RL, Martin PR, Botha H, Schwarz CG, Duffy JR, Petersen RC, Knopman DS, Clark HM, Butts AM, Machulda MM, Jack CR Jr, Lowe VJ, Whitwell JL, Josephs KA. Utianski RL, et al. Cortex. 2020 Mar;124:33-43. doi: 10.1016/j.cortex.2019.11.002. Epub 2019 Nov 19. Cortex. 2020. PMID: 31830664 Free PMC article.
Primary progressive apraxia of speech (PPAOS) is a term used to describe a neurodegenerative condition in which apraxia of speech (AOS; a planning and/or programming deficit) occurs in the absence of aphasia (a language deficit). PPAOS is strongly associated with 4-repeat …
Primary progressive apraxia of speech (PPAOS) is a term used to describe a neurodegenerative condition in which apraxia of speech (AOS; a pl …
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
Mundada NS, Rojas JC, Vandevrede L, Thijssen EH, Iaccarino L, Okoye OC, Shankar R, Soleimani-Meigooni DN, Lago AL, Miller BL, Teunissen CE, Heuer H, Rosen HJ, Dage JL, Jagust WJ, Rabinovici GD, Boxer AL, La Joie R. Mundada NS, et al. Alzheimers Res Ther. 2023 Sep 22;15(1):157. doi: 10.1186/s13195-023-01302-w. Alzheimers Res Ther. 2023. PMID: 37740209 Free PMC article.
However, the relationship between p-tau and tau-PET is less characterized within cognitively impaired patients with a biomarker-supported diagnosis of AD. ...Regional PET-plasma associations varied with amyloid burden, with p-tau217 being more stron …
However, the relationship between p-tau and tau-PET is less characterized within cognitively impaired patients with a b …
Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly.
Chhatwal JP, Schultz AP, Marshall GA, Boot B, Gomez-Isla T, Dumurgier J, LaPoint M, Scherzer C, Roe AD, Hyman BT, Sperling RA, Johnson KA. Chhatwal JP, et al. Neurology. 2016 Aug 30;87(9):920-6. doi: 10.1212/WNL.0000000000003050. Epub 2016 Jul 29. Neurology. 2016. PMID: 27473132 Free PMC article.
OBJECTIVE: To better understand cross-sectional relationships between CSF and PET measures of tau pathology, we compared regional and global measures of (18)F-T807 (AV-1451) PET to CSF protein levels of total tau (t-tau), phosphorylated tau …
OBJECTIVE: To better understand cross-sectional relationships between CSF and PET measures of tau pathology, we compared regio …
Associations between [(18)F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.
La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, Rosen HJ, Tsai R, Visani AV, Miller BL, Jagust WJ, Rabinovici GD. La Joie R, et al. Neurology. 2018 Jan 23;90(4):e282-e290. doi: 10.1212/WNL.0000000000004860. Epub 2017 Dec 27. Neurology. 2018. PMID: 29282337 Free PMC article.
In the full sample, cortical [(18)F]AV1451 was associated with all CSF biomarkers, most strongly with p-tau (r = 0.75 vs 0.57 for t-tau and -0.49 for Abeta(42)). When restricted to Abeta-positive patients with AD, [(18)F]AV1451 SUVR correlated modestly …
In the full sample, cortical [(18)F]AV1451 was associated with all CSF biomarkers, most strongly with p-tau (r = 0.75 vs 0.57 …
Amyloid and tau PET demonstrate region-specific associations in normal older people.
Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ. Lockhart SN, et al. Neuroimage. 2017 Apr 15;150:191-199. doi: 10.1016/j.neuroimage.2017.02.051. Epub 2017 Feb 21. Neuroimage. 2017. PMID: 28232190 Free PMC article.
We examined local (same region) and non-local (different region) associations between these 2 aggregated proteins in 46 normal older adults using [(18)F]AV-1451 (for tau) and [(11)C]PiB (for Abeta) positron emission tomography (PET) and 1.5T mag …
We examined local (same region) and non-local (different region) associations between these 2 aggregated proteins in 46 normal older adults …
PET Tau and Amyloid-beta Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
Koychev I, Gunn RN, Firouzian A, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Rochester L, Ffytche D, Howard R, Zetterberg H, MacKay C, Lovestone S; Deep and Frequent Phenotyping study team (. Koychev I, et al. J Alzheimers Dis. 2017;60(1):283-293. doi: 10.3233/JAD-170129. J Alzheimers Dis. 2017. PMID: 28800330 Free PMC article.
BACKGROUND: Combining PET amyloid-beta (Abeta) and tau imaging may be critical for tracking disease progression in Alzheimer's disease (AD). ...RESULTS: 22 participants took part in the study with 20 completing its 6-month duration and 12 having both tau …
BACKGROUND: Combining PET amyloid-beta (Abeta) and tau imaging may be critical for tracking disease progression in Alzh …
Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography.
Li Y, Yao Z, Yu Y, Zou Y, Fu Y, Hu B; Alzheimer’s Disease Neuroimaging Initiative. Li Y, et al. BMC Psychiatry. 2019 Jun 3;19(1):165. doi: 10.1186/s12888-019-2149-9. BMC Psychiatry. 2019. PMID: 31159754 Free PMC article.
This study aims to explore the associations of spatial patterns between Abeta deposition and tau deposition in patients with MCI and normal control (NC). METHODS: We used multimodality positron emission tomography (PET) data from a clinically he …
This study aims to explore the associations of spatial patterns between Abeta deposition and tau deposition in patients with MCI and …
13 results